NCT02339415View on ClinicalTrials.gov

Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
InflammationCoagulationHIV Infection
Interventions
DRUG

Edoxaban 30mg daily

DRUG

Matching placebo

Trial Locations (2)

55415

Hennepin County Medical Center, Minneapolis

55417

Hennepin County Medical Center, Minneapolis

Sponsors
All Listed Sponsors
lead

Hennepin Healthcare Research Institute

OTHER